Journals / Turkish Journal of Medical Sciences / 2019 / Cilt: 49 - Sayı: 2

Elevated neutrophil to lymphocyte ratio as an indicator of secondary erythema nodosum, a retrospective observational study

Pages
624–634
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

EN patients were grouped as idiopathic EN and secondary EN (EN with an identified underlying cause).Clinical and laboratory characteristics of the two groups were compared.Results: NLR was elevated in EN patients compared to controls (median of 2.38 vs. 1.55, P 2.11), RDW-CV (> 13.65), and CRP (> 5.5)were identified as risk factors for secondary EN (relative risks were 17.16, 2.69, and 2, respectively).Conclusion: Elevated NLR (> 2.11) may be used as a parameter to discriminate secondary EN from idiopathic EN.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Erythema nodosum (EN) is an inflammatory disorder of subcutaneous tissue.
📊
Key Findings & Data:The aim of our study isto investigate NLR in EN patients and evaluate its relation to the underlying cause of the disease.Materials and methods: Between 2014 and 2018, clinical and laboratory data of 395 patients diagnosed with EN and 395 controls wereextracted from patient files.
💡
Conclusion & Impact:EN patients were grouped as idiopathic EN and secondary EN (EN with an identified underlying cause).Clinical and laboratory characteristics of the two groups were compared.Results: NLR was elevated in EN patients compared to controls (median of 2.38 vs. 1.55, P 2.11), RDW-CV (> 13.65), and CRP (> 5.5)were identified as risk factors for secondary EN (relative risks were 17.16, 2.69, and 2, respectively).Conclusion: Elevated NLR (> 2.11) may be used as a parameter to discriminate secondary EN from idiopathic EN.
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Background/aim: Erythema nodosum (EN) is an inflammatory disorder of subcutaneous tissue. Although etiopathogenesis of thedisease is unknown, many predisposing factors such as infections, systemic disease, and drugs have been identified. Neutrophil tolymphocyte ratio (NLR) has been shown to be a novel inflammatory marker in many dermatological diseases. The aim of our study isto investigate NLR in EN patients and evaluate its relation to the underlying cause of the disease.Materials and methods: Between 2014 and 2018, clinical and laboratory data of 395 patients diagnosed with EN and 395 controls wereextracted from patient files. EN patients were grouped as idiopathic EN and secondary EN (EN with an identified underlying cause).Clinical and laboratory characteristics of the two groups were compared.Results: NLR was elevated in EN patients compared to controls (median of 2.38 vs. 1.55, P 2.11), RDW-CV (> 13.65), and CRP (> 5.5)were identified as risk factors for secondary EN (relative risks were 17.16, 2.69, and 2, respectively).Conclusion: Elevated NLR (> 2.11) may be used as a parameter to discriminate secondary EN from idiopathic EN.

🔖

Cite This Article

ÖKTEM, A., YALÇIN, B., UYSAL, P. İ., ŞAHİN, B., HAYRAN, Y., ALLI, N. (2022). Elevated neutrophil to lymphocyte ratio as an indicator of secondary erythema nodosum, a retrospective observational study. Turkish Journal of Medical Sciences, Cilt: 49 - Sayı: 2, 624–634. https://ajindex.com/articles/610245

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Requena L, Yus ES. Panniculitis. Part I. Mostly septal panniculitis. Journal of the American Academy of Dermatology 2001; 45 (2): 163-183
  2. Ginarte M, Toribio J. Sweet’s syndrome and erythema nodosum: two neutrophilic dermatoses? Clinical Rheumatology 2007; 26 (7): 1215-1216
  3. Kunz M, Beutel S, Brocker E. Leucocyte activation in erythema nodosum. Clinical and Experimental Dermatology 1999; 24 (5): 396-401
  4. Kakourou T, Drosatou P, Psychou F, Aroni K, Nicolaidou P. Erythema nodosum in children: a prospective study. Journal of the American Academy of Dermatology 2001; 44 (1): 17-21
  5. Mert A, Ozaras R, Tabak F, Pekmezci S, Demirkesen C et al. Erythema nodosum: an experience of 10 years. Scandinavian Journal of Infectious Diseases 2004; 36 (6-7): 424-427
  6. Cribier B, Caille A, Heid E, Grosshans E. Erythema nodosum and associated diseases. A study of 129 cases. International Journal of Dermatology 1998; 37 (9): 667-672
  7. Requena L, Yus ES. Erythema nodosum. Dermatologic Clinics 2008; 26 (4): 425-438
  8. Fox MD, Schwartz RA. Erythema nodosum. American Family Physician 1992; 46 (3): 818-822
  9. Papagrigoraki A, Gisondi P, Rosina P, Cannone M, Girolomoni G. Erythema nodosum: etiological factors and relapses in a retrospective cohort study. European Journal of Dermatology 2010; 20 (6): 773-777
  10. Zahorec R. Ratio of neutrophil to lymphocyte counts – rapid and simple parameter of systemic inflammation and stress in critically ill. Bratislavske Lekarske Listy 2001; 102 (1): 5-14
  11. Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA et al. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. American Journal of Cardiology 2008; 102 (6): 653-657
  12. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. Journal of Surgical Oncology 2005; 91 (3): 181-184
  13. Imtiaz F, Shafique K, Mirza SS, Ayoob Z, Vart P et al. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. International Archives of Medicine 2012; 5 (1): 2
  14. Sen BB, Rifaioglu EN, Ekiz O, Inan MU, Sen T et al. Neutrophil to lymphocyte ratio as a measure of systemic inflammation in psoriasis. Cutaneous and Ocular Toxicology 2014; 33 (3): 223- 227
  15. Jiang Y, Ma W. Assessment of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in atopic dermatitis patients. Medical Science Moni